9 Meters Biopharma Inc NMTR:NASDAQ

Last Price$0.29Cboe Previous Close - Real-Time Last Sale as of 3:59PM ET 8/16/22
Cboe Real-Time Quotes
Today's Change0(0.00%)
Bid (Size)$0.29 (3)
Ask (Size)$0.33 (100)
Day Low / HighN/A - N/A
Volume2.6 K
 

View Biotechnology IndustryPeer Comparison as of 08/16/2022

 

9 Meters Biopharma Inc ( NASDAQ )

Price: $0.29
Change: +0.003 (1.17%)
Volume: 2.6 K
3:59PM ET 8/16/2022
 
 

Synlogic Inc ( NASDAQ )

Price: $1.09
Change: 0.00 (0.00%)
Volume: 383.00
3:59PM ET 8/16/2022
 
 

Quince Therapeutics Inc ( NASDAQ )

Price: $2.22
Change: -0.08 (3.48%)
Volume: 95.00
4:00PM ET 8/16/2022
 
 

Rubius Therapeutics Inc ( NASDAQ )

Price: $0.79
Change: +0.002 (0.31%)
Volume: 2.4 K
4:00PM ET 8/16/2022
 
 

Harpoon Therapeutics Inc ( NASDAQ )

Price: $2.11
Change: -0.03 (1.40%)
Volume: 29.00
3:59PM ET 8/16/2022
 

Read more news Recent News

--Maxim Downgrades 9 Meters Biopharma to Hold From Buy
10:41AM ET 7/01/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

9 Meters Biopharma Secures Debt Facility for Up to $70 Million
9:51AM ET 6/30/2022 MT Newswires

9 Meters Biopharma (NMTR) said Thursday that it has secured a senior secured convertible notes facility for up to $70 million with a single lender. The...

9 Meters Biopharma Achieves Positive Preliminary Results From Phase 2 Trial of Vurolenatide
7:56AM ET 6/30/2022 MT Newswires

9 Meters Biopharma (NMTR) said Thursday it has achieved positive preliminary topline results from its phase 2 trial of Vurolenatide for the treatment of...

--Maxim Group Adjusts 9 Meters Biopharma Price Target to $1 From $2, Maintains Buy Rating
9:16AM ET 6/22/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

View all Commentary and Analysis

9 Meters Biopharma Inc (NMTR) Investor Presentation - Slideshow
2:16PM ET 9/10/2021 Seeking Alpha

Company Profile

Business Description9 Meters Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on rare and unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs. The company is founded by Jay P. Madan and Kendyle Woodard in 2012 and is headquartered in Raleigh, NC. View company web site for more details
Address8480 Honeycutt Road
Raleigh, North Carolina 27615
Phone+1.919.275.1933
Number of Employees8
Recent SEC Filing08/15/20228-K
President, Chief Executive Officer & DirectorJohn Temperato
SVP-Corporate Development & OperationsSireesh Appajosyula
Chief Financial & Accounting OfficerBethany L. Sensenig
Chief Medical OfficerPatrick H. Griffin

Company Highlights

Price Open$0.30
Previous Close$0.29
52 Week Range$0.20 - 1.46
Market Capitalization$76.0 M
Shares Outstanding259.1 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement11/21/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.15
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit MarginN/A
Return on Equity-94.39%

Analyst Ratings as of 06/30/2022

Buy
5
Overweight
0
Hold
1
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset